Related references
Note: Only part of the references are listed.The proliferation rate paradox in antimitotic chemotherapy
Timothy J. Mitchison
MOLECULAR BIOLOGY OF THE CELL (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data
Darren R. Tyson et al.
NATURE METHODS (2012)
Phase I trials of targeted anticancer drugs: a need to refocus
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Subtype and pathway specific responses to anticancer compounds in breast cancer
Laura M. Heiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Exploring the Contextual Sensitivity of Factors that Determine Cell-to-Cell Variability in Receptor-Mediated Apoptosis
Suzanne Gaudet et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Adaptive informatics for multifactorial and high-content biological data
Bjorn L. Millard et al.
NATURE METHODS (2011)
Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance
Maame Efua S. Sampah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
Andrew C. Hsieh et al.
CANCER CELL (2010)
Molecular Target Class Is Predictive of In vitro Response Profile
Joel Greshock et al.
CANCER RESEARCH (2010)
mToR signaling and drug development in cancer
Janet Dancey
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions
Martin L. Sos et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis
Sabrina L. Spencer et al.
NATURE (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Lin Shen et al.
NATURE MEDICINE (2008)
Variability and robustness in T cell activation from regulated heterogeneity in protein levels
Ofer Feinerman et al.
SCIENCE (2008)
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
A. A. Cohen et al.
SCIENCE (2008)
Variability and memory of protein levels in human cells
Alex Sigal et al.
NATURE (2006)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis
M Bazzaro et al.
CANCER RESEARCH (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Application of the mutual information criterion for feature selection in computer-aided diagnosis
GD Tourassi et al.
MEDICAL PHYSICS (2001)
Chemosensitivity prediction by transcriptional profiling
JE Staunton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
